Pharmaceutical firm partners psychobiotic startup for first foray into microbiome modulation
31-MAY-2019
Neuraxpharm Group, a pharmaceutical firm focused on the central nervous system (CNS), has announced its first foray in the probiotics category after signing a European distribution deal with startup firm Bened Biomedical Co.
Comentarios